We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYB icon
76
LyondellBasell Industries
LYB
$19.9B
$1.92M 0.51%
19,355
-322
-2% -$29K
JBTM
77
JBT Marel
JBTM
$6.99B
$1.84M 0.49%
18,195
+8,764
+93% +$808K
SAFT icon
78
Safety Insurance
SAFT
$1.07B
$1.79M 0.48%
23,403
-1,231
-5% -$87.7K
PSX icon
79
Phillips 66
PSX
$83B
$1.69M 0.45%
18,393
+3,843
+26% +$326K
ZIXI
80
DELISTED
Zix Corporation
ZIXI
$1.68M 0.45%
343,053
+248,408
+262% +$1.31M
VTR icon
81
Ventas
VTR
$47.6B
$1.66M 0.44%
25,441
+3,036
+14% +$205K
MET icon
82
MetLife
MET
$59.5B
$1.59M 0.42%
30,608
+2,166
+8% +$105K
OGE icon
83
OGE Energy
OGE
$10.2B
$1.58M 0.42%
43,936
-497
-1% -$17.7K
DIS icon
84
Walt Disney
DIS
$161B
$1.44M 0.38%
14,617
-60,644
-81% -$6.24M
EGRX
85
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.43M 0.38%
24,000
– –
BPL
86
DELISTED
Buckeye Partners, L.P.
BPL
$1.42M 0.38%
24,980
-1,541
-6% -$91.6K
PATK icon
87
Patrick Industries
PATK
$2.83B
$1.38M 0.37%
36,934
+22,943
+164% +$757K
SANM icon
88
Sanmina
SANM
$11.7B
$1.36M 0.36%
+36,628
New +$1.37M
SCL icon
89
Stepan Co
SCL
$1.31B
$1.34M 0.36%
16,056
+7,493
+88% +$616K
SPY icon
90
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$1.31M 0.35%
5,232
-198
-4% -$48.8K
SLP icon
91
Simulations Plus
SLP
$371M
$1.2M 0.32%
77,364
+4,270
+6% +$62K
LGTY
92
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.2M 0.32%
105,203
-19,777
-16% -$201K
CBM
93
DELISTED
Cambrex Corporation
CBM
$1.08M 0.29%
+19,710
New +$1.08M
ADM icon
94
Archer Daniels Midland
ADM
$41.6B
$1.06M 0.28%
24,913
+6,677
+37% +$281K
JNJ icon
95
Johnson & Johnson
JNJ
$624B
$1.04M 0.28%
8,003
+214
+3% +$28.4K
UNH icon
96
UnitedHealth
UNH
$385B
$1M 0.27%
5,106
+196
+4% +$37.9K
AAPL icon
97
Apple
AAPL
$4.72T
$998K 0.27%
25,900
+1,512
+6% +$58.7K
IJH icon
98
iShares Core S&P Mid-Cap ETF
IJH
$122B
$996K 0.27%
27,840
-175
-0.6% -$6.09K
CBPX
99
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$989K 0.26%
38,026
+3,728
+11% +$86K
NEE icon
100
NextEra Energy
NEE
$187B
$969K 0.26%
26,448
+1,548
+6% +$56.7K
2 3
4
5 6

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.